Improved Overall Survival with Checkpoint Inhibition and Allogeneic Transplantation in Relapsed Hodgkin Lymphoma.
Tabbara N, Zahurak ML, Sterling C, Trutzer IM, Jedrych J, Swinnen LJ, Fuchs EJ, Bolaños-Meade J, Wagner-Johnston ND, Jones RJ, Ambinder RF, Varadhan R, Paul S.
Tabbara N, et al. Among authors: paul s.
Blood Adv. 2024 Dec 18:bloodadvances.2024015048. doi: 10.1182/bloodadvances.2024015048. Online ahead of print.
Blood Adv. 2024.
PMID: 39693511